Akers Biosciences revenue ahead of expectations
19th Jul 2013 07:28
Akers Biosciences said first-half revenue was ahead of its own expectations after it capitalised on demand for its disposable breath alcohol detectors. In a trading update, Akers said it had delivered 4.9m of the detectors to its global partner, Chubeworkx. The Chube-branded detectors are certifi
Read moreAkers Biosciences gets boost from new French regulation
19th Feb 2013 11:27
Akers Biosciences was rewarded with a 11.3 per cent jump in its share price as the company announced a new product launch into the French market. The launch of disposable breath alcohol analysis tools is timely, as it coincides with a new French law coming into effect as of July 2012 citing that e
Read moreSmall caps: Iofina, WYG, Akers Biosciences
17th Sep 2012 07:34
WYG, a management and technical consultancy to the built and natural environment, says it will report a small operating profit in the first six months of the current year. The group is also poised to buy all three of WYG Ireland's subsidiaries in Northern Ireland, securing the jobs of around 90 empl
Read moreLondon close: Footsie finishes below best levels
6th Jan 2012 17:17
London closed comfortably below its best levels of the day despite better than expected US jobless data which had some market commentators crying 'foul'. US non-farm payrolls grew by 200,000 during the month of December. The consensus estimate was for a reading of 155,000. Morgan Stanley has sugges
Read moreAkers' profit expectations down the tubes
6th Jan 2012 09:31
Diagnostic screening and testing products developer Akers Biosciences slumped to a 52-week low after warning that 2011 revenues will not come up to scratch. Largely as a result of issues with an order for Revelar Breath Tubes from Pulse Health, revenues for 2011 will be significantly below expectat
Read moreAkers narrows losses after sales surge in 2010
11th Apr 2011 16:00
Shares in screening and testing products group Akers Biosciences surged after the company reported a 72% increase in revenue after a "momentum-building" year. Revenue for the 12 months ended 31 December grew to $3.1m, from $1.8m in 2009, as a result of strong sales of its HIT-testing product ('PIFA
Read moreSmall caps round-up: Superglass, Akers Biosciences, TT electronics...
14th Jan 2011 14:00
Insulation products maker Superglass is experiencing solid trading with specialist distributors and builders' merchants, but, as anticipated, there has been a slow start to the newly extended carbon emissions reduction target (CERT) programme. The expectation is that the company's trading performa
Read moreUK SMALLCAP ROUNDUP: Eckoh Sees Return To 1H 2011 Profit
21st Jun 2010 16:00
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps ECKOH PLC (ECK.LN), a voice recognition specialist, expects to return to a profit in the first half of fiscal 2011 after posting a narrowed pretax loss f
Read moreUK SMALLCAP ROUNDUP: Photo-Me Fined GBP500,000 By FSA
21st Jun 2010 12:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps PHOTO-ME INTERNATIONAL PLC (PHTM.LN), a photo booth operator, was Monday fined GBP500,000 by the U.K. Financial Services Authority for failing to keep in
Read moreSmall caps round-up: Connemara Mining, Circle Oil, Kenetics...
21st Jun 2010 11:34
Irish zinc explorer Connemara Mining has intersected additional high grade zinc-lead mineralisation 400m to the southwest of the Stonepark North discovery in Limerick. "The Stonepark discovery in Limerick is getting bigger and better," said chairman John Teeling. Circle Oil is "even more convince
Read moreUK SMALLCAP ROUNDUP: GW Pharm Seeks More EU Sativex Approvals
21st Jun 2010 08:53
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps GW PHARMACEUTICALS PLC (GWP.LN), a drug company, Monday said it will apply to sell multiple sclerosis medicine Sativex in other European countries during
Read moreAkers Biosciences 2009 Pretax Loss Widens On Lower US Govt Spending
21st Jun 2010 08:41
LONDON (Dow Jones)--Diagnostics company Akers Biosciences Inc. (AKR.LN) Monday posted a much wider full-year pretax loss due to a hiatus in U.S. government departmental spending as federal funds were diverted to aiding economic recovery. The U.S. government is a major customer for the company.
Read moreSmall caps round-up: Conexion, Condor, Capcon...
18th Jun 2010 13:25
Music copyright group Conexion Media narrowed losses in the year to December 31 despite lower revenues. Pre-tax losses fell to £630,000 from £1.6m on revenues that were down to £3.4m from £4m. Conexion, which specialises in the administration of film and TV related music rights, won deals newspape
Read moreUK SMALLCAP ROUNDUP: Egdon Resources Up On Production Boost
14th Jun 2010 16:00
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps EGDON RESOURCES PLC (EDR.LN), an oil and gas company, Monday said it intends to revive plans to generate electricity from gas produced from its Keddingto
Read moreUPDATE: Akers Biosciences Signs Up Thermo Fisher In US
14th Jun 2010 14:56
(Adds executive comment, share price) By Rachael Gormley and Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--Diagnostics company Akers Biosciences Inc. (AKR.LN) said Monday it signed up Thermo Fisher Scientific Inc. (TMO) as its second U.S. distributor for a test designed to hel
Read more